NASDAQ:INDP | Cash Flow Statement | Indaptus Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$1.79M
2026-03-31-$2.54M-$7.01M
2025-12-31-$8.11M-$3.19M$5.87M
2025-09-30-$2.98M
2025-06-30-$5.23M
2025-03-31-$4.53M-$5.05M$3.15M
2024-12-31-$4.13M-$3.4M$1.8M
2024-09-30-$3.07M
2024-06-30-$4.02M
2024-03-31-$3.81M-$3.94M$316,047.00
2023-12-31-$4M-$2.6M$0.00
2023-09-30-$3.92M
2023-06-30-$3.25M
2023-03-31-$4.25M-$4.96M$2.14M
2022-12-31-$3.66M-$2.21M$5.12M
2022-09-30-$3.47M
2022-06-30-$3.84M
2022-03-31-$3.37M-$3.12M-$2.8M
2021-12-31-$3.22M-$3.54M$0.00$451,600.00$363,058.00
2021-09-30-$3.37M
2021-06-30-$515,479.00
2021-03-31-$612,421.00-$825,584.00$3.68M
2020-12-31-$770,219.00-$957,030.00-$3,957.00
2020-09-30-$1.54M
2020-06-30-$712,618.00
2020-03-31-$558,581.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$20.85M-$14.82M$17.54M
2024-12-31-$15.02M-$12.32M$4.75M
2023-12-31-$15.42M-$13.41M$17.14M
2022-12-31-$14.32M-$13.08M-$16.43M
2021-12-31-$7.71M-$11.29M$3,854.00$447,746.00$48.34M
2020-12-31-$3.58M-$3.32M$1.16M